Details for New Drug Application (NDA): 213076
✉ Email this page to a colleague
The generic ingredient in MUPIROCIN is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 213076
Tradename: | MUPIROCIN |
Applicant: | Encube |
Ingredient: | mupirocin calcium |
Patents: | 0 |
Pharmacology for NDA: 213076
Mechanism of Action | RNA Synthetase Inhibitors |
Suppliers and Packaging for NDA: 213076
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 213076 | ANDA | Encube Ethicals Private Limited | 21922-029 | 21922-029-04 | 1 TUBE in 1 CARTON (21922-029-04) / 15 g in 1 TUBE |
MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 213076 | ANDA | Encube Ethicals Private Limited | 21922-029 | 21922-029-05 | 1 TUBE in 1 CARTON (21922-029-05) / 30 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | EQ 2% BASE | ||||
Approval Date: | Aug 31, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription